AI Brain Mapping Tool Gets FDA Green Light for Neurosurgery

Washington University School of Medicine in St. Louis has developed an AI-based brain mapping technology that has received FDA authorization for use in neurosurgery. The Cirrus Resting State fMRI Software rapidly identifies critical brain areas controlling functions like speech and movement, enhancing precision in tumor removal and epilepsy treatment. This technology, licensed to startup Sora Neuroscience, analyzes brain activity patterns in just 12 minutes of fMRI scanning. It offers broader accessibility for brain mapping, including for patients who struggle with traditional task-based fMRI